SubsidieMeestersNovel highly sensitive NanoWire sensors for disease biomarker analysis
Aligned Bio's project aims to achieve TRL9 by developing a cost-effective method for mass-producing high-quality nanowire sensors, enhancing biomarker detection sensitivity by 20 times.
Projectdetails
Introduction
Nanowire-based platforms are expected to radically impact disease diagnosis and precision medicine thanks to their high surface-area-to-footprint ratio and optical waveguiding properties. The challenge is to cost-effectively produce nanowires in a reproducible manner.
Technology Development
At Aligned Bio, we have developed a new technology that enables, for the first time, mass- and cost-effective production of nanowire sensors. Our solution relies on three core patented technologies, which when combined, allow us to produce low-cost, high-quality nanowires with controlled diameters to reproducibly enhance waveguiding properties of nanowire platforms.
Unique Advantages
This unique combination of novel technologies results in enhanced biomarker detection platform devices with:
- 20 times higher sensitivity than current solutions in the market
- Crucially, a low price
Project Importance
To effectively carry out the tasks needed to reach TRL9, the EIC Accelerator project is crucial to bridging the critical risk-gap.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.315.943 |
| Totale projectbegroting | € 3.308.491 |
Tijdlijn
| Startdatum | 1-6-2022 |
| Einddatum | 30-9-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- ALIGNEDBIO ABpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Transforming Molecular Diagnostics through NanoTechnologyAltratech Ltd aims to revolutionize molecular diagnostics by using patented nanotechnology for rapid, non-clinical detection of viruses and pathogens without biological amplification. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological diseasesINBRAIN Neuroelectronics is developing AI-powered graphene-based neural implants to enhance resolution and specificity in neuroelectronic therapies for refractory neurological disorders. | EIC Accelerator | € 2.493.750 | 2023 | Details |
Transforming Molecular Diagnostics through NanoTechnology
Altratech Ltd aims to revolutionize molecular diagnostics by using patented nanotechnology for rapid, non-clinical detection of viruses and pathogens without biological amplification.
Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological diseases
INBRAIN Neuroelectronics is developing AI-powered graphene-based neural implants to enhance resolution and specificity in neuroelectronic therapies for refractory neurological disorders.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Injectable nanoelectrodes for wireless and minimally invasive neural stimulationDeveloping minimally invasive, nanoscale, wireless neuroelectrodes for targeted neural stimulation to improve treatment accessibility for neurological impairments. | ERC Starting... | € 1.499.725 | 2023 | Details |
Nanowire device for single virus delivery and sensing in vacuumVIR-Quantify aims to develop a novel technology for rapid, sensitive airborne virus detection and infectivity assessment, enhancing public health response and enabling commercialization. | ERC Proof of... | € 150.000 | 2024 | Details |
New Generation HealthcareToxgensolutions onderzoekt de toepassing van miR-technologie voor vroege diagnose van ziekten met een nanotechnologie microsensor. | Mkb-innovati... | € 20.000 | 2022 | Details |
Multianalyte Continuum Nanopores SensingMC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment. | ERC Proof of... | € 150.000 | 2024 | Details |
Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platformNanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs. | EIC Transition | € 2.489.571 | 2022 | Details |
Injectable nanoelectrodes for wireless and minimally invasive neural stimulation
Developing minimally invasive, nanoscale, wireless neuroelectrodes for targeted neural stimulation to improve treatment accessibility for neurological impairments.
Nanowire device for single virus delivery and sensing in vacuum
VIR-Quantify aims to develop a novel technology for rapid, sensitive airborne virus detection and infectivity assessment, enhancing public health response and enabling commercialization.
New Generation Healthcare
Toxgensolutions onderzoekt de toepassing van miR-technologie voor vroege diagnose van ziekten met een nanotechnologie microsensor.
Multianalyte Continuum Nanopores Sensing
MC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment.
Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platform
NanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs.